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Abstract Sentrin-1/SUMO-1 is a novel ubiquitin-like protein,
which can covalently modify a limited number of cellular
proteins. Here we report the identification of the sentrin-
activating enzyme complex, which consists of two proteins
AOS1 and UBA2. Human AOS1 is homologous to the N-
terminal half of E1, whereas human UBA2 is homologous to the
C-terminal half of E1. The human UBA2 gene is located on
chromosome 19q12. Human UBA2 could form a L-mercap-
toethanol-sensitive conjugate with members of the sentrin family,
but not with ubiquitin of NEDD8, in the presence of AOS1.
Identification of human UBA2 and AOS1 should allow a more
detailed analysis of the enzymology of the activation of ubiquitin-
like proteins.
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1. Introduction
Protein modi¢cation by ubiquitin has been studied exten-
sively in the last two decades [1,2]. The ATP-dependent ubiq-
uitination reaction is carried out by a multi-step pathway.
Initially, the ubiquitin-activating enzyme (E1) utilizes ATP
to adenylate the ubiquitin C-terminus, which is then trans-
ferred to a conserved Cys residue in the E1, resulting in the
formation of a high-energy thiol ester bond between ubiquitin
and E1. This thiol ester bond is subsequently transferred to a
Cys residue in one of many ubiquitin-conjugating enzymes
(E2). The ¢nal transfer of ubiquitin to an O-amino group of
a lysine residue in the target protein may require a ubiquitin
ligase (E3) enzyme. During the last three years, post-transla-
tional modi¢cation of proteins by ubiquitin-like proteins has
rapidly become a very active and signi¢cant area of research.
We previously reported the cloning of a ubiquitin-like protein,
sentrin-1, which interacts speci¢cally with the death domains
of both Fas and tumor necrosis factor receptor 1 [3]. Sentrin-1
and its yeast homologue, SMT3, have been shown to cova-
lently modify a limited number of cellular proteins in a proc-
ess analogous to protein ubiquitination [4^10]. Activation of
SMT3 requires the cooperation of two yeast proteins, UBA2
and AOS1 [10] which are homologous to the C- or N-terminal
portion of E1, respectively. It is not known whether sentrin-1
is also activated by a similar enzyme complex in mammalian
cells. In this report, we describe the cloning and character-
ization of the human UBA2 and AOS1 genes from a placenta
cDNA library. We show that both UBA2 and AOS1 are re-
quired for the activation of all sentrin family members. These
data strengthen the hypothesis that both sentrin and SMT3
share a similar conjugating pathway and demonstrate that the
ubiquitin- and sentrin/SMT3-conjugating pathways diverged
from each other at an early stage.
2. Materials and methods
2.1. cDNA cloning of the human UBA2 and AOS1
To clone human UBA2, we initially performed a tBLASTn search
of the TIGR Tentative Human Consensus Sequences (THCs) data-
base using the partial sequence of human UBE1 protein (amino acids
450 to 500) containing the ATP-binding region. Seventeen positive
THC fragments were identi¢ed. The nucleotide sequence of one pos-
itive THC fragment (THC206278) was used to perform another
BLAST search of the TIGR THCs database. One of the positive
THC fragments (THC175035) was shown to partially overlap with
THC206278. A further search of TIGR THCs database using
THC175035 resulted in identi¢cation of THC159422. PCR ampli¢ca-
tion was used to con¢rm the cDNA sequence. Two oligonucleotide
primers generated according to the information from THC206278
were used to extend the cDNA sequence towards the 5P direction by
RACE method. Extension of the cDNA towards the 3P direction was
performed by RACE with the oligonucleotides generated from
THC159422. Using a pair of redesigned 5P and 3P primers compatible
with the sequence revealed in the 5P and 3P anchored PCR reactions,
we then ampli¢ed a 2.7 kb cDNA fragment by PCR reaction.
To identify the human AOS1 gene, we used the yeast AOS1 amino
acid sequence to screen the EST databases for human ESTs encoding
putative AOS1 homologue. The tBLASTn searches identi¢ed a num-
ber of matching human ESTs. AA176210 is the longest (546 bp) of
these cDNAs. A search of the EST database with the nucleotide
sequence from AA176210 identi¢ed two additional ESTs (AA313766
and N57252). A further search of the human EST database using
N57252 identi¢ed H98166. PCR ampli¢cation was used to con¢rm
the cDNA sequence. Nested primers were designed to the 5P and
3P end of the clone, and gene ampli¢cation using DNA from the
cDNA library was utilized to recover two fragments containing
more of the 5P and 3P ends.
2.2. PCR and RACE ampli¢cation of cDNA fragment
Unless otherwise speci¢ed, the PCR reaction was carried out in a
volume of 50 Wl that contained 50 mM KCl, 2 mM MgCl2, 0.2 mM
dNTP, 10 mM Tris-HCl, pH 8.3, 100 ng of each primer, and 25 units
of Pfu polymerase, which possesses proof reading activity (Clontech),
on a PTC-200 programmable thermal cycler (MJ Research Inc.). The
reaction mixture was denatured at 94‡C for 4 min, and the ampli¢-
cation reaction consisted of 30 cycles of denaturation (94‡C, 30 s),
annealing (55‡C, 50 s), and extension (72‡C, 1 min) with a ¢nal ex-
tension at 72‡C for 5 min. For RACE, nested primers speci¢c to
human UBA2 cDNA and nested adaptor primers were used in the
primary and secondary PCRs. A thermal cycling pro¢le of 94‡C for
30 s, 65‡C for 30 s, and 72‡C for 90 s (25 cycles) was used in the
primary PCR, with a human placenta cDNA library being used as a
template. A cycling pro¢le of 94‡C for 50 s and 70‡C for 3 min
(30 cycles) was used for the secondary PCR, with 1 Wl of the primary
PCR product functioning as a template.
2.3. DNA sequencing and analysis
The DNA sequence of the identi¢ed clones was determined on both
strands using Applied Biosystems Prism dye termination DNA se-
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quencing reagents and an automated ABI 377 sequencer (Applied
Biosystems).
2.4. Expression and puri¢cation of GST fusion proteins
The plasmids pGEX-UB, pGEX-NEDD8, and pGEX-sentrin-1, -2,
and -3 were used for expression of GST fusion proteins. The GEX
expression vectors were introduced into competent BL21 bacteria, and
expression of GST fusion proteins was induced with isopropyl-L-D-
thiogalactopyranoside and puri¢ed as described previously [12].
2.5. In vitro translation
For in vitro translation of UBA2 and AOS1, we constructed
pcDNA3-UBA2 and pcDNA3-AOS1 plasmids by inserting full length
UBA2 and AOS1, respectively, into the pcDNA3 vector. The resulting
plasmids were used as templates for in vitro transcription and trans-
lation using T7 RNA polymerase (Promega) under conditions recom-
mended by the supplier. Translation reaction were performed in TNT
T7-coupled rabbit reticulocyte lysates (Promega) in a ¢nal volume of
50 Wl. Reaction mixtures contained 25 Wl of lysate, 40 WCi of
[35S]methionine (1000 Ci/mmol), 15 units of RNasin (Promega),
50 WM amino acid mixture (minus methionine), and 1 Wg of DNA.
The reactions were incubated for 90 min at 30‡C and stopped with the
addition of three volumes of Laemmli bu¡er. Translation products
were analyzed using 15% SDS-polyacrylamide gel electrophoresis.
Gels were ¢xed, treated in amplify solution (Amersham), dried, and
processed for autoradiography.
2.6. GST-pulled down assay
To demonstrate interaction between ubiquitin, NEDD8, or sentrin-
1 and UBA2, 10 Wl of in vitro translated, [35S]-labeled UBA2 were
incubated with 50 Wl of glutathione-Sepharose beads containing ap-
proximately 1 Wg of GST, GST-UB, GST-NEDD8 or GST-sentrin-1
for 30 min at room temperature in a solution of 20 mM Tris-HCl (pH
7.52), 50 mM NaCl, 10 mM MgCl2, 0.1 mM DTT, 4 mM ATP and
5 U/ml inorganic pyrophosphatase. After washing ¢ve times with the
same bu¡er, the samples were treated with SDS loading bu¡er and
loaded onto a 15% SDS-polyacrylamide gel and visualized by auto-
radiography. In order to demonstrate the formation of UBA2-sentrin
conjugates, the above reaction was terminated following a 10 min
incubation time in the presence of AOS1. Brie£y, 10 Wl of
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Fig. 1. Sequence alignment of human UBE1, UBA3, UBA2 and yeast UBA2. Amino acids that are identical to the corresponding position are
shaded black. The human UBA2 sequence is deposited in the GenBank database with the accession number AF079566.
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[35S]methionine-labeled UBA2 and 40 Wl of AOS1 were mixed with
50 Wl of glutathione-Sepharose beads containing approximately 1 Wg
of GST, GST-UB, GST-NEDD8 or GST-sentrin-1 for 10 min at
room temperature in a solution of 20 mM Tris-HCl (pH 7.52),
50 mM NaCl, 10 mM MgCl2, 0.1 mM DTT, 4 mM ATP and 5 U/
ml inorganic pyrophosphatase. The reactions were terminated with
the addition of SDS-containing loading bu¡er.
3. Results and discussion
3.1. Cloning of the human UBA2 cDNA
In an e¡ort to identify the activating enzyme for sentrin, we
searched the Tentative Human Consensus Sequences (THCs)
database generated by the Institute for Genomic Research
(TIGR). Using an approach described in Section 2, a 2683
bp cDNA fragment was cloned from a human placenta
cDNA library. The cloned cDNA contains an open reading
frame encoding a protein of 640 amino acid residues. The
amino acid sequence was compared with sequences in several
databases using the BLAST network service at the National
Center for Biotechnology Information. As shown in Fig. 1,
the predicted amino acid sequence is more closely related to
yeast UBA2 (33% identity) than human UBA3 (22% identity)
[11] or the C-terminal portion of human E1 (24% identify).
We named this protein UBA2 because of its close homology
to yeast UBA2 and its ability to form a thiol ester bond with
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Fig. 2. In vitro interaction of ubiquitin, NEDD8, and sentrin-1 with
UBA2. In vitro translated UBA2 (lane 1) was precipitated by GST-
sentrin-1 (lane 2), GST-NEDD8 (lane 3), GST-ubiquitin (lane 4)
and GST (lane 5) in the presence of ATP.
Fig. 3. Sequence alignment of human UBE1, APP-BP1, AOS1 and yeast AOS1. Amino acids that are identical to the corresponding position
are shaded black. The human AOS1 nucleotide sequence is deposited in the GenBank database with the accession number AF046025.
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sentrin family members (see below). The calculated molecular
weight, based on the cDNA derived amino acid sequence of
human UBA2, is 71.5 kDa, identical to the kDa value esti-
mated by SDS-PAGE analysis (see below).
3.2. Chromosomal localization of the human UBA2 gene by
EST mapping
To determine the chromosomal localization of the human
UBA2, we employed an EST mapping strategy. The human
UBA2 cDNA sequence was used to search the GenBank EST
database using the BLAST program, resulting in the positive
identi¢cation of 79 EST clones. All EST clones were subse-
quently used to check the Human Gene Map database. Eight
clones, namely AA017441 (nt position 2216^2682), AA029770
(nt position 2199^2682), AA088220 (nt position 2199^2682),
AA169833 (nt position 2265^2682), AA132238 (nt position
2275^2682), H09723 (nt position 2211^2676), N50800 (nt po-
sition 2366^2682), and D57425 (nt position 2295^2550), have
been mapped to chromosome 19 between the D19S222 and
D19S425 microsatellite markers at 49^58 centimorgans (Na-
tional Center for Biotechnology Information). Thus, the
UBA2 gene is located on chromosome 19q12. Both E1-like
genes UBE1L and UBA3 are located in chromosome 3,
whereas E1 (UBE1) is located in chromosome X.
3.3. Human UBA2 could bind to sentrin-1, ubiquitin, and
NEDD8 in vitro
To determine whether UBA2 might directly associate with
sentrin-1, we employed a modi¢ed GST-pulled down assay.
GST fusion proteins of ubiquitin, NEDD8, and sentrin-1,
bound to GSH beads, were incubated with in vitro translated
UBA2 at room temperature for various periods of time in the
presence of ATP. The GST beads were extensively washed
and the precipitated proteins were analyzed with SDS-
PAGE. As shown in Fig. 2, UBA2 translated in vitro results
in two major bands (72 and 62 kDa) (Fig. 2, lane 1). This is
most likely due to di¡erential usage of the two ATG codons
(91^93, 379^381) in the UBA2 sequence. Both UBA2 bands
could be precipitated by GST-ubiquitin (Fig. 2, lane 2), GST-
NEDD8 (Fig. 2, lane 3), and GST-sentrin-1 (Fig. 2, lane 4),
but not with GST (Fig. 2, lane 5). Similar binding pattern
could be observed in the absence of ATP (data not shown).
No higher molecular weight conjugate was observed in any of
these GST-pulled down assays, suggesting that UBA2 alone
cannot form a thiol ester conjugate with sentrin-1.
3.4. Cloning of human AOS1
The fact that human UBA2 is similar to the C-terminal
region of E1, but lacks a region homologous to the N-termi-
nus of E1, and the failure of UBA2 to form a thiol ester
conjugate with sentrin-1 suggests that an unidenti¢ed cofactor
might be required for sentrin-1 activation. During our study
of human UBA2, Johnson et al. [10] reported that the yeast
homologue of sentrin-1, SMT3, is activated by an enzyme
complex composed of UBA2 and AOS1. Since SMT3 and
sentrin-1 both utilized UBC9 as a speci¢c conjugating enzyme
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Fig. 4. Formation of UBA2-sentrin conjugates. A: Formation of a 120 kDa conjugate of UBA2 and sentrin-1 (lane 3), sentrin-2 (lane 4), and
sentrin-3 (lane 5) in the presence of AOS1. B: The conjugates between UBA2 and sentrin family members (lanes 4, 5, and 7) were sensitive to
L-mercaptoethanol treatment (lanes 6, 8, and 9).
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[12^14], it is likely that another component, similar to yeast
AOS1, is required for sentrin-1 activation. In order to clone
the human AOS1 gene, we used the yeast AOS1 amino acid
sequence to screen the EST database for human ESTs encod-
ing putative AOS1 homologues. Using a strategy similar to
the one used to clone UBA2, we cloned a 2119 bp cDNA. The
cloned fragment encodes a 346 amino acid polypeptide,
AOS1. A comparison of the deduced amino acid sequence
of the AOS1 protein with that of yeast AOS1 shows 34%
identity and 54% similarity (Fig. 3). Further analysis revealed
a highly conserved region in the N-termini of AOS1 (AA
position 17^57), E1, and APP-BP1 (a subunit of the
NEDD8-activating complex [11]). This conserved region has
revealed quite a few interesting amino acid substitutions,
which may provide some insight into the manner in which
these di¡erent enzymes function biochemically, as well as a
basis for their substrate speci¢city. First of all, AOS1 and
APP-BP1 have a negatively charged aspartic acid at position
20 (in human AOS1), whereas E1 has an uncharged, polar
serine residue at the corresponding position. Another interest-
ing substitution occurs at position 24 (in human AOS1) where
both AOS1 and APP-BP1 have a positively charged arginine
residue and E1 has an uncharged, polar tyrosine residue.
Lastly, both AOS1 and APP-BP1 have an uncharged, polar
glutamine residue at position 31 (AOS1), whereas E1 has a
non-polar methionine residue at that position.
3.5. Both UBA2 and AOS1 are required for sentrin activation
To con¢rm that sentrin-1 activation requires both UBA2
and AOS1, [35S]met-labeled UBA2 and in vitro translated
AOS1 were mixed and incubated with GST-sentrin-1 and
ATP. As shown in Fig. 4A, a GST-sentrin-1-UBA2 conjugate
of V120 kDa was visualized (lane 3). In contrast, neither
ubiquitin (lane 1) nor NEDD8 (lane 2) can form this 120
kDa conjugate. The formation of the GST-sentrin-1-UBA2
conjugate requires the presence of AOS1 (compare lane 3
and lane 6). We were unable to observe any UBA2-ubiquitin
conjugation product following longer exposure of the gel.
Furthermore, ubiquitin could not be conjugated to UBA2 in
the presence of ATP and AOS1 with a range of incubation
time from 10 min to 2 h. Importantly, this 120 kDa band
could be destroyed by L-mercaptoethanol treatment, suggest-
ing that it is a thiol ester linked conjugate (Fig. 4B). It is
important to note that these thiol ester conjugate occurs with-
in 10 min of incubation. However, we were unable to detect
any thiol ester conjugate beyond 15 min, raising the possibility
that sentrin, once activated, is quickly transferred to UBC9
present in our translation mix. There are three sentrin family
members [8,9,15^17] that have overlapping substrate speci¢c-
ity. We also demonstrated that sentrin-2 or sentrin-3 could
form a L-mercaptoethanol-sensitive conjugate with UBA2
(Fig. 4B, lanes 4 and 5). Thus, all of the sentrin family mem-
bers can be activated by the UBA2/AOS1 enzyme complex.
Acknowledgements: We would like to thank L.S. Caskey for technical
help. This work was supported in part by National Institute of Health
Grant HL-45851 and an Established Investigator Award from the
American Heart Association (to E.T.H.Y.).
References
[1] Hershko, A. and Ciechanover, A. (1998) Annu. Rev. Biochem.
67, 425^479.
[2] Wilkinson, K.D. (1995) Annu. Rev. Nutr. 15, 161^189.
[3] Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei,
C.F., Chang, H.M. and Yeh, E.T.H. (1996) J. Immunol. 157,
4277^4281.
[4] Mahajan, R., Delphin, C., Guan, T., Gerace, L. and Melchior, F.
(1997) Cell 88, 97^107.
[5] Matunis, M.J., Coutavas, E. and Blobel, G. (1996) J. Cell Biol.
135, 1457^1470.
[6] Desterro, J.M.P., Rodriguez, M.S. and Hay, R.T. (1998) Mol.
Cell 2, 233^239.
[7] Boddy, M.N., Howe, K., Etkin, L.D., Solomon, E. and Free-
mont, P.S. (1996) Oncogene 13, 971^982.
[8] Kamitani, T., Nguyen, H.P. and Yeh, E.T.H. (1997) J. Biol.
Chem. 272, 14001^14004.
[9] Kamitani, T., Nguyen, H.P., Kito, K., Fukuda-Kamitani, T. and
Yeh, E.T.H. (1998) J. Biol. Chem. 273, 3117^3120.
[10] Johnson, E.S., Schwienhorst, I., Dohmen, R.J. and Blobel, G.
(1997) EMBO J. 16, 5509^5519.
[11] Gong, L. and Yeh, E.T.H. (1999) J. Biol. Chem., in press.
[12] Gong, L., Kamitani, T., Fujise, K., Caskey, L. and Yeh, E.T.H.
(1997) J. Biol. Chem. 272, 28198^28201.
[13] Johnson, E.S. and Blobel, G. (1997) J. Biol. Chem. 272, 26799^
26802.
[14] Saitoh, H., Pu, R., Cavenagh, M. and Dasso, M. (1997) Proc.
Natl. Acad. Sci. USA 94, 3736^3741.
[15] Kamitani, T., Kito, K., Nguyen, H.P. and Yeh, E.T.H. (1997)
J. Biol. Chem. 272, 28557^28562.
[16] Kamitani, T., Kito, K., Nguyen, H.P., Fukuda-Kamitani, T. and
Yeh, E.T.H. (1998) J. Biol. Chem. 274, 11349^11353.
[17] Kamitani, T., Kito, K., Nguyen, H.P., Wada, H., Fukuda-Ka-
mitani, T. and Yeh, E.T.H. (1998) J. Biol. Chem. 273, 26675^
26682.
FEBS 21835 29-3-99
L. Gong et al./FEBS Letters 448 (1999) 185^189 189
